Connect your AI

Vivani Medical VANI Operating Cash Flow

Operating Cash Flow at other companies

Eli LillyLLY

$5.33B+220%

AmgenAMGN

$2.19B+57.4%

AltimmuneALT

-$20.94M-24.4%

Viking TherapeuticsVKTX

-$113.98M-118%

Wave Life SciencesWVE

-$59.55M+5.5%

Prime MedicinePRME

-$42.71M+12.6%

Other financials

Income statement

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vivani Medical's operating cash flow?: Vivani Medical (VANI) reported operating cash flow of -$6.2M in Q1 2026.
How has Vivani Medical's operating cash flow changed year-over-year?: Vivani Medical's operating cash flow decreased by 20.0% year-over-year, from -$5.16M to -$6.2M.
What is the long-term trend for Vivani Medical's operating cash flow?: Over 4 years (2021 to 2025), Vivani Medical's operating cash flow has grown at a 22.1% compound annual growth rate (CAGR), from -$10.95M to -$24.32M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.